 |
International Cancer Immunotherapy Conference 2019
September 25th – 29th 2019 Espace Grande Arche, Paris, France |
Invectys will be attending the International Cancer Immunotherapy Conference 2019 in Paris.
This immuno-oncology conference will unite the scientists, clinicians, regulators, drug developers, and patient advocates in the field of cancer immunotherapy.
Invectys will be presenting clinical study results for INVAC-1, its DNA anti-telomerase vaccine and lead product.
If you would like to set up a meeting, feel free to contact us at contact@invectys.com.
